Table 2 Characteristics of intranasal fresh breast milk (iFBM) administration
From: F-NEO-BRIGHT: feasibility and safety of intranasal fresh breast milk in neonatal encephalopathy
Total (n = 10) | |
|---|---|
iFBM therapy initiated (h) | 24.7 (14.8–40.2) |
iFBM therapy duration (days) | 28 (23.7–28) |
iFBM therapy total doses | 50.0 (39.7–54.5) |
iFBM therapy doses at home | 23 (12–36.2) |
Enteral feeding initiated (h) | 27 (20.5–54.5) |
Time to reach full enteral feeding (days) | 8 (7–13) |
